Levoxyl and Nitrofurantoin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levoxyl (levothyroxine sodium) and Nitrofurantoin (nitrofurantoin, macrocrystalline). Common drug interactions include blood triglycerides increased among females and dehydration among males.

The phase IV clinical study analyzes what interactions people have when they take Levoxyl and Nitrofurantoin. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Levoxyl?

Levoxyl has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 25,178 Levoxyl users. Check the latest studies of Levoxyl.

What is Nitrofurantoin?

Nitrofurantoin has active ingredients of nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 4,837 Nitrofurantoin users. Check the latest studies of Nitrofurantoin.



On Jul, 09, 2026

28 people who take Levoxyl and Nitrofurantoin together, and have interactions are studied.

Levoxyl and Nitrofurantoin drug interactions.

What are the common drug interactions of Levoxyl and Nitrofurantoin, by gender? *:

female:

  1. Blood triglycerides increased
  2. Cardiac disorder
  3. Chills (felling of cold)
  4. Chronotropic incompetence (inability of the heart to increase its rate appropriately in response to increased activity or metabolic need)
  5. Cold sweat
  6. Colitis (inflammation of colon)
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Cough
  9. Dehydration (dryness resulting from the removal of water)
  10. Drug effect decreased

male:

  1. Dehydration (dryness resulting from the removal of water)
  2. Diarrhoea
  3. Amylase increased
  4. Depression
  5. Fall
  6. Fatigue (feeling of tiredness)
  7. Food intolerance (inability to have food)
  8. Hypophagia (reduced food intake)
  9. Immune reconstitution syndrome (immune recovery syndrome)
  10. Insomnia (sleeplessness)

What are the common drug interactions of Levoxyl and Nitrofurantoin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Bile duct stone
  2. Depression
  3. Duodenal ulcer
  4. Immune reconstitution syndrome (immune recovery syndrome)
  5. Oral fungal infection
  6. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)

50-59:

  1. Incisional hernia (hernia caused by an incompletely-healed surgical wound)
  2. Injection site induration
  3. Post procedural haematoma (post procedural clotting of blood)
  4. Procedural site reaction
  5. Osteoporosis (bones weak and more likely to break)
  6. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  7. Incision site haemorrhage (bleeding from incision site)

60+:

  1. Diarrhoea
  2. Haematochezia (passage of stools containing blood)
  3. Fall
  4. Fatigue (feeling of tiredness)
  5. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  6. Vomiting
  7. Weight decreased
  8. Flushing (the warm, red condition of human skin)
  9. Actinic keratosis (skin disease due to sun exposure)
  10. Arrhythmia (irregular heartbeat)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 17.86%
  2. Osteoporosis (bones weak and more likely to break): 4 people, 14.29%
  3. High Blood Cholesterol: 4 people, 14.29%
  4. Pain: 3 people, 10.71%
  5. Asthma: 3 people, 10.71%
  6. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 7.14%
  7. High Blood Pressure: 2 people, 7.14%
  8. Heart Rate Irregular: 2 people, 7.14%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Levoxyl and Nitrofurantoin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levoxyl and Nitrofurantoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levoxyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nitrofurantoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levoxyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitrofurantoin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium and nitrofurantoin, macrocrystalline (the active ingredients of Levoxyl and Nitrofurantoin, respectively), and Levoxyl and Nitrofurantoin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: